1. Home
  2. ANGI vs EYPT Comparison

ANGI vs EYPT Comparison

Compare ANGI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • EYPT
  • Stock Information
  • Founded
  • ANGI 1995
  • EYPT 1987
  • Country
  • ANGI United States
  • EYPT United States
  • Employees
  • ANGI N/A
  • EYPT N/A
  • Industry
  • ANGI Advertising
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • ANGI Consumer Discretionary
  • EYPT Industrials
  • Exchange
  • ANGI Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • ANGI 566.2M
  • EYPT 484.4M
  • IPO Year
  • ANGI 2017
  • EYPT 2005
  • Fundamental
  • Price
  • ANGI $15.00
  • EYPT $8.42
  • Analyst Decision
  • ANGI Hold
  • EYPT Strong Buy
  • Analyst Count
  • ANGI 8
  • EYPT 8
  • Target Price
  • ANGI $20.33
  • EYPT $24.75
  • AVG Volume (30 Days)
  • ANGI 977.6K
  • EYPT 917.5K
  • Earning Date
  • ANGI 08-05-2025
  • EYPT 08-06-2025
  • Dividend Yield
  • ANGI N/A
  • EYPT N/A
  • EPS Growth
  • ANGI N/A
  • EYPT N/A
  • EPS
  • ANGI 1.03
  • EYPT N/A
  • Revenue
  • ANGI $1,125,635,000.00
  • EYPT $56,042,000.00
  • Revenue This Year
  • ANGI N/A
  • EYPT N/A
  • Revenue Next Year
  • ANGI $4.24
  • EYPT N/A
  • P/E Ratio
  • ANGI $14.54
  • EYPT N/A
  • Revenue Growth
  • ANGI N/A
  • EYPT 12.04
  • 52 Week Low
  • ANGI $10.88
  • EYPT $3.91
  • 52 Week High
  • ANGI $29.15
  • EYPT $13.99
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 43.40
  • EYPT 59.17
  • Support Level
  • ANGI $15.09
  • EYPT $8.50
  • Resistance Level
  • ANGI $15.87
  • EYPT $9.60
  • Average True Range (ATR)
  • ANGI 0.54
  • EYPT 0.59
  • MACD
  • ANGI -0.26
  • EYPT -0.01
  • Stochastic Oscillator
  • ANGI 3.14
  • EYPT 52.61

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: